Ginsenoside Rk3 modulates gut microbiota and regulates immune response of group 3 innate lymphoid cells to against colorectal tumorigenesis.

"Declaration of competing interest The authors declare that there are no conflicts of interest."

"This work was supported by the 10.13039/501100012166National Key Research and Development Program, China (Grant Nos.: 2021YFC2101500 and 2021YFC2103900), the 10.13039/501100001809National Natural Science Foundation of China (Grant Nos.: 22278335 and 21978236), and the Natural Science Basic Research Program of Shaanxi, China (Grant No.: 2023-JC-JQ-17). Xue Bai: Investigation, Methodology, Validation, Project administration, Formal analysis, Data curation, Writing - Original draft preparation, Visualization; Rongzhan Fu: Validation, Methodology, Supervision, Project administration; Writing - Reviewing and Editing, Visualization, Formal analysis, Funding acquisition; Yannan Liu: Methodology, Formal analysis, Supervision, Visualization; Jianjun Deng: Data curation, Investigation, Funding acquisition; Qiang Fei: Investigation, Project administration, Supervision; Zhiguang Duan: Methodology, Formal analysis, Supervision; Chenhui Zhu: Resources, Project administration, Supervision, Writing - Reviewing and Editing, Funding acquisition; Daidi Fan: Resources, Project administration, Supervision, Funding acquisition."